Compound Summary


sirolimus
  Compound Information
 sirolimus

Compound Name:

sirolimus

Compound CID:

5284616

Synonyms:

(-)-Rapamycin

53123-88-9

AY 22989

AY-22989

I 2190A

More...

Iupac Name:

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

InChI:

InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1

InChIKey:

QFJCIRLUMZQUOT-HPLJOQBZSA-N

Canonical Smiles:

CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC

Isomeric Smiles:

C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC

Molecular Weight:

914.2

Molecular Formula:

C51H79NO13

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 sirolimus

Molecular Weight:

914.2

Molecular Formula:

C51H79NO13

Hydrogen Bond Donor Count:

3

Hydrogen Bond Acceptor Count:

13

Rotatable Bond Count:

6

Heavy Atom Count:

65

Complexity:

1760

  Synonyms
 sirolimus

sirolimus sirolimus

(-)-Rapamycin

53123-88-9

AY 22989

AY-22989

I 2190A

I-2190A

I2190A

NSC 226080

RAPA

Rapammune

Rapamune

Rapamycin

SIIA 9268A

Sirolimus

Wy 090217

rapalimus

Rapamycin (Sirolimus)

WY-090217

Rapamycin (GMP)

FYARRO

HYFTOR

L04AA10

Npc-12g

Antibiotic AY 22989

CHEBI:9168

W36ZG6FT64

SM-88 COMPONENT SIROLIMUS

DE-109

MFCD00867594

NSC-226080

NCGC00021305-05

sirolimusum

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexylpropan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido2,1-c1,4oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

SILA 9268A

Supralimus

Rapamycin/Sirolimus

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexylpropan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo30.3.1.0(4,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

CAS-53123-88-9

Perceiva

Cypher

CCRIS 9024

NSC226080

HSDB 7284

1fkb

1pbk

NCGC00181146-01

LCP-Siro

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-(1R)-2-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl-1-methylethyl-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido2,1-c1,4oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido2,1-c1,4oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone

RAP

S1039

SIROLIMUS INN

SIROLIMUS JAN

RAPAMYCIN MI

SIROLIMUS HSDB

SIROLIMUS USAN

SIROLIMUS VANDF

BiomolKI2_000084

SIROLIMUS MART.

SCHEMBL3463

SIROLIMUS USP-RS

SIROLIMUS WHO-DD

Rapamycin,Sirolimus,Rapamune

UNII-W36ZG6FT64

BIDD:PXR0165

SIROLIMUS EMA EPAR

MLS006010168

Sirolimus USAN:INN:BAN

GTPL6031

SIROLIMUS ORANGE BOOK

DTXSID5023582

BDBM36609

MS-R001

RAPA, Rapamune, Sirolimus, RPM

HMS2089A21

HMS3403F11

HMS3884C03

EX-A1044

RPM

Tox21_110870

Tox21_112750

AC-722

BDBM50064359

HY-10219G

STL570275

AKOS015850976

AKOS015961618

ZINC169289388

CCG-100684

CS-0063

DB00877

NAB-RAPAMYCIN COMPONENT RAPAMYCIN

NSC-2260804

NCGC00021305-06

NCGC00021305-07

Rapamycin from Streptomyces hygroscopicus

AS-11687

HY-10219

SMR004701276

Fyarro (sirolimus albumin-bound particles)

EVEROLIMUS IMPURITY A EP IMPURITY

UNM-0000358684

A-275

CS-0626126

R0097

Rapamycin, VETRANAL(TM), analytical standard

EC 610-965-5

M02444

Q32089

123R889

Q-201659

BRD-K84937637-001-04-0

BRD-K84937637-001-06-5

BRD-K89626439-001-01-0

Z2568665260

24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypy

Rapamycin from Streptomyces hygroscopicus, >=95% (HPLC), powder

Rapamycin from Streptomyces hygroscopicus, Vetec(TM) reagent grade, >=95%

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexylpropan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo30.3.1.04,9hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34 aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hex adecahydro-9,27-dihydroxy-3-(1R)-2-(1S,3R,4R)-4-hydro xy-3-methoxycyclohexyl-1-methylethyl-10,21-dimethoxy- 6,8,12,14,20,26-hexamethyl-23,27-ep

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-4,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-heptadecahydro-9,27-dihydroxy-3-(1R)-2-(1S,3,4R)-4-hydroxy-3-methoxycyclohexyl-1-methylethyl-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-223,27-Epoxy-3H-pyrido2,1-c1,4oxaazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{1-(1S,3R,4R)-4-hydroxy-3-methoxycyclohexylpropan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,

1,18-Dihydroxy-12-2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo30.3.1.0*4,9*hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (Rapamycin)

  Experimental Data
 sirolimus

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Caenorhabditis elegans 50.000000000000000 umol/L 12.150000000000000 S N2 30970250 Active
Caenorhabditis elegans 50.000000000000000 umol/L 16.140000000000000 S N2 30970250 Active
  Experimental Data Visualization
 sirolimus

  Statistics Data
 sirolimus

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Caenorhabditis elegans 16.140000000000000 1 2
  Statistics Data Visualization
 sirolimus